Gil Issachar
pursuant to which Issachar now serves as the Head of AI and Neuroscience of the Company.
Highest-materiality recent filing
Firefly Neuroscience terminates $1M securities purchase agreement with investor
Terminated purchase agreement to sell up to 666,667 units at $1.50 each for gross proceeds of $1,000,000.
Firefly Neuroscience CTO Gil Issachar transitions to Head of AI; no longer executive officer
Gil Issachar steps down as CTO and executive officer; becomes Head of AI and Neuroscience effective June 18, 2026.
Issued 5,333,333 Units at $1.50 per Unit for total proceeds of $8,000,000 to an accredited investor.
Firefly Neuroscience raises $2.25M in private placement; potential additional $18M
Issued 1.5M units at $1.50/unit to accredited investors for $2.25M in initial closing.
Firefly exchanges June 2025 warrants for new $0.50 warrants, expects $400K proceeds
Cancels 800,000 warrants at $3.50/$4.00 strikes; issues new warrants for 800,000 shares at $0.50.
Firefly terminates $10M ELOC with Arena; CFO Krzywicki salary raised
Terminated ELOC agreement with Arena Business Solutions, effective Sept 11, 2025.
Firefly Neuroscience acquires Evoke Neuroscience; expands database, IP, commercial footprint
Purchase price $6M: 50% cash ($3M) and 50% common stock (857,143 shares at $3.50), plus $500K earn-out in cash if Evoke achieves $3M annualized revenues within 3 years.
David DeCaprio appointed President and COO effective April 18, 2025; receives $250k base salary, bonus up to 50%, and RSU award of 263,952 shares.
Firefly Neuroscience appoints Greg Lipschitz as CEO under 3-year employment agreement
Greg Lipschitz appointed CEO effective March 26, 2025; base salary $300k/yr, eligible for 50% bonus and performance bonus.
Firefly Neuroscience CEO Jon Olsen removed; Greg Lipschitz named interim CEO
Jon Olsen resigned from board on Dec 30, 2024, effective immediately; no disagreement cited.
Firefly raises up to $12.4M via convertible note and ELOC; CMO resigns
$2.4M convertible note with Helena Special Opportunities at $3.00/share; net proceeds $2.04M after OID.
Firefly Neuroscience names Greg Lipschitz Executive Chairman; David Johnson resigns
David Johnson resigned as Executive Chairman and director effective Nov 30, 2024; resignation not due to any disagreement.
Firefly Neuroscience FY2023 net loss $2.6M, revenue $498K; raises $3.5M private placement
FY2023 revenue $498K vs $0 in 2022; net loss $2.6M vs $3.9M; operating loss $3.1M.
Firefly Neuroscience appoints David Johnson as Executive Chairman, grants 5% restricted stock award
David Johnson appointed Executive Chairman; monthly salary of $12,500 ($150,000 annual).
Firefly Neuroscience completes reverse merger with WaveDancer; reports H1 2024 net loss of $2.4M
Merger closed Aug 12, 2024; Firefly shareholders own ~92% of combined company (NASDAQ: AIFF).
Merger closed Aug 12, 2024; Firefly becomes wholly owned sub; former Firefly stockholders own ~92% of combined company, WaveDancer stockholders ~8%.
Gross proceeds of ~$3.5M from shares & warrants at $0.442/unit; warrants exercisable at $0.71 for 5 years.
WaveDancer extends credit line maturity to July 16, 2024 with $200k principal paydown
Executed Change of Terms on $1M line (currently $500k outstanding) extending maturity from May 16 to July 16, 2024.
WaveDancer auditor CohnReznick resigns; no disagreements cited
CohnReznick resigned as independent auditor on May 16, 2024; no disagreements or reportable events occurred.
FireFly Neuroscience adds AI healthcare leader David DeCaprio to board ahead of WaveDancer merger
David DeCaprio, co-founder of ClosedLoop.ai and former Broad Institute engineer, to join FireFly's board upon merger close.
WaveDancer and Firefly receive stockholder approvals for merger; close expected Q2 2024
Both WaveDancer and Firefly stockholders voted majority support on March 14, 2024, for merger proposals.
WaveDancer shareholders approve all five merger-related proposals in special meeting
Shareholders approved Nasdaq Proposal (share issuance) with 1,094,466 for, 79,292 against.
Firefly white paper shows BNA platform boosts MDD treatment compliance 15%, cuts med switches >50%
Analysis of 2,253 patients at a U.S. psychiatric clinic using Firefly’s BNA Platform.
WaveDancer sets March 14 vote on Firefly merger; S-4 declared effective
Shareholder vote on WaveDancer-Firefly merger scheduled for March 14, 2024.
WaveDancer files S-4 for merger with Firefly Neuroscience; expects close Q2 2024
S-4 registration statement filed with SEC for previously announced merger with Firefly Neuroscience.
Effective Time of merger must occur prior to or simultaneous with the Tellenger Sale.
WaveDancer to merge with Firefly Neuroscience, sell Tellenger, rename as Firefly
WaveDancer (WAVD) merges with private Firefly; Firefly holders get 88-92% of combined entity.
WaveDancer shareholders approve reverse stock split; board sets ratio at 1-for-10
Stockholders approved amendment to Certificate of Incorporation for reverse split (96.0% for).
Stockholders' equity was $2,371,318 as of March 31, 2023, below the $2,500,000 minimum.
WaveDancer receives Nasdaq delisting notice for bid price and equity non-compliance
Received delisting determination on June 8, 2023; trading suspension set for June 20, 2023 unless appeal.
WaveDancer sells GMI subsidiary for $1M cash and 20% stake; records $7.8-8.2M impairment
Sold subsidiary Gray Matters to GMDC (StealthPoint-led) for $1M cash, 20% equity interest in buyer, and up to $4M contingent payments over 7 years.
WaveDancer receives Nasdaq deficiency notice for bid price below $1.00
Received Nasdaq letter on Dec 9, 2022, for failing minimum bid price of $1.00 over 30 consecutive days.
WaveDancer Q3 2022 revenue down 47% to $2.3M, net loss $4.7M including goodwill impairment
Total revenues $2.3M vs $4.3M YoY; professional fees $2.1M vs $2.8M.
pursuant to which Issachar now serves as the Head of AI and Neuroscience of the Company.
On April 18, 2025, the Board of Directors (the “Board”) of Firefly Neuroscience, Inc. (the “Company”) appointed David DeCaprio (“DeCaprio”) as the President and Chief Operating Officer of the Company.
On March 26, 2025, the board of directors of the Company (the “Board”) appointed Greg Lipschitz as the Chief Executive Officer of the Company.
the board of directors (the “Board”) of the Company elected Arun Menawat as the Chairman of the Company, effective immediately.
On March 10, 2025, Greg Lipschitz resigned from his position as the Executive Chairman of Firefly Neuroscience, Inc. (the “Company”), effective immediately. Mr. Lipschitz remains as a director of the Company.
On December 30, 2024, Jon Olsen resigned from his position as a member of the board of directors (the “Board”) of Firefly Neuroscience, Inc. (the “Company”), effective immediately.
In addition, on January 6, 2025, the Board removed Mr. Olsen from his position as the Company’s Chief Executive Officer without cause and appointed Greg Lipschitz as the Company’s Interim Chief Executive Officer.
In addition, on January 6, 2025, the Board removed Mr. Olsen from his position as the Company’s Chief Executive Officer without cause and appointed Greg Lipschitz as the Company’s Interim Chief Executive Officer.
appointed David Johnson and Stella Vnook to the Board, with Mr. Johnson to serve as Executive Chairman of the Board pursuant to the Johnson Employment Agreement (as defined herein), effective as of August 19, 2024.
appointed David Johnson and Stella Vnook to the Board, with Mr. Johnson to serve as Executive Chairman of the Board pursuant to the Johnson Employment Agreement (as defined herein), effective as of August 19, 2024.
with David DeCaprio, Jon Olsen, Greg Lipschitz and Brian Posner to serve on the Board
each of G. James Benoit, Jr., Jack L. Johnson, Jr., William H. Pickle, Paul B. Becker, James C. DiPaula, Jr. and Bonnie K. Wachtel resigned as members of the WaveDancer Board
Max materiality 0.90 · Median 0.62 · Most common event other_material